Lescol sNDA For Post-Angioplasty Adds 1 Mil. Potential Patients Per Year
Executive Summary
Reliant will target the 1 mil. U.S. patients who undergo angioplasty procedures each year who could benefit from Lescol (fluvastatin) and Lescol XL after approval of an expanded indication for the statin May 27